Novavax tumbles 31% as waning COVID-19 vaccine demand hits revenue forecast
August 09, 2022 at 11:34 AM EDT
Novavax fell 31% Tuesday amid falling demand for the COVID-19 shot from low and middle-income nations, which caused the company to cut its annual expectations in half.
